(Q37278117)

19 August 2017

A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH). (English)

1 reference

non-alcoholic steatohepatitis

19 August 2017

0 references

0 references

1 reference

1 reference

4

Yock-Young Dan

1 reference

19 August 2017

Yin-Mei Lee

1

1 reference

19 August 2017

Dede S Sutedja

2

1 reference

19 August 2017

Chun-Tao Wai

3

1 reference

19 August 2017

Myat-Oo Aung

5

1 reference

19 August 2017

Lei Zhou

6

1 reference

19 August 2017

Chee-Leong Cheng

7

1 reference

19 August 2017

Aileen Wee

8

1 reference

19 August 2017

Seng-Gee Lim

9

1 reference

19 August 2017

28 February 2008

1 reference

19 August 2017

Hepatology international

1 reference

19 August 2017

2

1 reference

19 August 2017

2

1 reference

19 August 2017

196-201

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Nonalcoholic fatty liver disease: an agenda for clinical research

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Cytokines in alcoholic liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716847

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

3 September 2018

1 reference

12 December 2020

Pentoxifylline and alcoholic hepatitis

1 reference

12 December 2020

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

12 December 2020

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

10.1007/S12072-008-9058-1

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19669304

1 reference